Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation

PHASE3UnknownINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

April 30, 2017

Conditions

Atrial Fibrillation

Interventions

DRUG

Spironolactone

DRUG

Placebo

Trial Locations (1)

Department of Cardiovascular Research, Medical Department, Odense University Hospital, Svendborg, Svendborg